China Isotope & Radiation Corporation
HKSE: 1763.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Junqi Zhang
- Employees
- 3,367
- Headquarters
- Beijing, China
- IPO year
- 2018
- Market cap
- HK$6.1B
- Website
- https://www.circ.com.cn
Loading 1763…
Loading profile data…Frequently asked questions about 1763
What does China Isotope & Radiation Corporation (1763.HK) do?
China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. It operates through five segments: Pharmaceuticals; Radioactive Source Products; Irradiation; Radiation Therapy E...
Where does 1763.HK trade?
China Isotope & Radiation Corporation (1763.HK) trades on the Hong Kong Stock Exchange.
What sector is 1763.HK in?
China Isotope & Radiation Corporation (1763.HK) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of China Isotope & Radiation Corporation?
Junqi Zhang is the chief executive officer of China Isotope & Radiation Corporation (1763.HK).
Where is China Isotope & Radiation Corporation headquartered?
China Isotope & Radiation Corporation is headquartered in China.
Does 1763.HK pay a dividend?
Yes — China Isotope & Radiation Corporation (1763.HK) paid a trailing twelve-month dividend of HKD 0.34 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 1763.HK go public?
China Isotope & Radiation Corporation (1763.HK) completed its initial public offering in 2018.